Příloha 7:
Přehled citací
Citace prací s prvoautorstvím:
Hamal, P., Kappe, R., Rimek, D. Rate of transmission and endogenous origin of Candida albicans and
Candida glabrata on adult intensive care units studied by pulsed field gel electrophoresis. J. Hosp. Infect.,
2001, vol. 49, no. 1, p. 37-42.
1. Sandt, C., Sockalingum, G.D., Aubert, D., Lepan, H., Lepouse, C., Jaussaud, M., Leon,
A., Pinon, J.M., Manfait, M., Toubas, D. Use of Fourier-transform infrared spectroscopy
for typing of Candida albicans strains isolated in intensive care units. J. Clin. Microbiol.,
2003, vol. 41, no. 3, p. 954-959. (SCI)
2. Taylor, B.N., Harrer, T., Pscheidl, E., Schweizer, A., Rollinghoff, M., Schroppel, K.
Surveillance of nosocomial transmission of Candida albicans in an intensive care unit by
DNA fingerprinting. J. Hosp. Infect., 2003, vol. 55, no. 4, p. 283-289. (SCI)
3. Saracli, M.A., Sener, K., Gonlum, A., Yildiran, S.T., Wickes, B.L. Genotyping of clinical
Rhodotorula mucilaginosa isolates by pulsed field gel electrophoresis. Mycoses, 2003,
vol. 46, no. 11-12, p. 487-491. (SCI)
4. Lasheras, A., Rogues, A.M., Peyrere, S., Boulard, G., Bebear, C.M., Gachie, J.P.,
Bretagne, S., Dromer, F. Candida albicans outbreak in a neurosurgical intensive care unit.
J. Hosp. Infect., 2007, vol. 65, no. 2, p. 181-182. (SCI)
5. Grenouillet, F., Millon, L., Bart, J.M., Roussel, S,, Biot, I., Didier, E., Ong, A.S.,
Piarroux, R. Multiple-locus variable-number tandem-repeat analysis for rapid typing of
Candida glabrata. J. Clin. Microbiol., 2007, vol. 45, no. 11, p. 3781-3784. (SCI)
6. Korabečná, M., Liška, V., Fajfrlík, K. Možnosti aplikace molekulárně genetických metod
v lékařské mykologii. Epidemiol. Mikrobiol. Imunol., 2003, vol. 52, čís. 1, s. 25–33.
7. Gouin, F. Infections fungiques (1). Société Française d’Anesthésie et de Réanimation,
2003 (http://www.sfar.org/s/imprimersans.php3?id_article=188).
Hamal, P., Dostál, J., Raclavský, V., Krylová, M., Pichová, I., Hrušková-Heidingsfeldová O. Secreted
aspartate proteinases, a virulence factor of Candida spp.: Occurrence among clinical isolates. Folia
Microbiol., 2004, vol. 49, no. 4, p. 491-496.
8. Kalkanci, A., Tuncer, C., Degertekin, B., Eren, A., Kustimur, S., Ilhan, M.N., Dursun, A.
Detection of Candida albicans by culture, serology and PCR in clinical specimens from
patients with ulcerative colitis: re-evaluation of an old hypothesis with a new perspective.
Folia Microbiol., 2005, vol. 50, no. 3, p. 263-267. (SCI)
9. Kalkanci, A., Bozdayi, G., Biri, A., Kustimur, S. Distribution of secreted aspartyl
proteinases using a polymerase chain reaction assay with SAP specific primers in Candida
albicans isolates. Folia Microbiol., 2005, vol. 50, no. 5, p. 409-413. (SCI)
10. Růžička, F., Holá, V., Votava, M., Tejkalová, R. Importance of biofilm in Candida
parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric
method. Folia Microbiol., 2007, vol. 52, no. 3, p. 209-214. (SCI)
11. Costa, F., Manaia, C.M., Figueiral, M.H., Pinto, E. Genotypic analysis of Candida
albicans isolates obtained from removable prosthesis wearers. Lett. Appl. Microbiol.,
2008, vol. 46, no. 4, p. 445-449. (SCI)
Hamal, P., Koukalová, D., Hájek, V. Naše zkušenosti s klasifikací kvasinkovitých mikroorganismů. I.
Kombinovaná biotypizační metoda podle Mencla a Otčenáška a typizace s využitím „killer“ fenomenu.
Epidemiol. Mikrobiol. Imunol., 1998, roč. 47, čís. 3, s. 87-92.
12. Krajewska-Kułak, E., Łukaszuk, C., Niczyporuk, W., Bartoszewicz, M., Roszkowska, I.,
Szczurzewski, M., Trybuła, J. Biotypy enzymatyczne szczepów grzybów
drożdżopodobnych izolowanych z różnych ontocenoz. Mikol. Lek., 2001, vol. 8, no. 1, p.
13-17.
13. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Hamal, P. Současné možnosti antimykotické terapie. Zprav. Klin. Farmakol. Farmac., 1994, roč. 8, čís.
1-2, s. 4-8.
14. Viktorinová, M. Zevní léčba houbových infekcí kůže. Zprav. Klin. Farmakol. Farmac.,
1994, roč. 8, čís. 3-4, s. 20-22.
Hamal, P., Dobiášová, S., Kocmanová, I., Jedličková, A., Lázničková, T., Buchta, V., Bergerová, T.,
Mallátová, N., Štolbová, M., Koláčková, M., Makimura, K. Candidemia in large Czech hospitals 2000 –
2002: An epidemiological study. Abstracts of the 15th Congress of the International Society for Human
and Animal Mycology. San Antonio, 2003, p. 463.
15. Bialková, A., Šubík, J. Biology of the pathogenic yeast Candida glabrata. Folia
Microbiol. 2006, vol. 51, no. 1, p. 3-20.
16. Haber, J., Mallátová, N., Kocmanová, I. Invazivní mykózy. Epidemiologie, diagnostika a
léčba. Praha: Pfizer, spol.s.r.o., 2007.
17. Haber, J., Mallátová, N., Kolešková, E., Hnátková, M., Kořen, J. Epidemiologie invazivní
kandidózy a kandidémie – stále aktuální problém. Anest. Intenziv. Med., 2008, roč. 19, čís.
2, s. 114-123.
Hamal, P., Kocmanová I., Jedličková, A., Hajíčková, M., Olišarová, P., Bergerová, T., Hanzlíčková, J.,
Buchta, V., Lazničková, T., Štolbová, M., Mallátová, N., Doležalová, J. Epidemiological analysis of
candidemia in Czech tertiary care hospitals in 2000 – 2006. J. Chemother., 2007, vol. 19, suppl. 3, p. 6162.
18. Haber, J., Mallátová, N., Kolešková, E., Hnátková, M., Kořen, J. Epidemiologie invazivní
kandidózy a kandidémie – stále aktuální problém. Anest. Intenziv. Med., 2008, roč. 19, čís.
2, s. 114-123.
Hamal, P., Raclavský, V., Hrušková, O., Píchová, I., Zelenková, I., Pavlíček, J., Hejnar, P.
Characterization of nosocomial Candida strains: resistance to antifungal agents, proteinase production,
RAPD typing. Mycoses, 1999, vol. 42, no. 3, p. 180-181.
19. Yücel, A., Kantarcioğlu A.S. Epidemiology of hospital acquired (nosocomial) fungal
infections. Cerrahpaşa J. Med. 2001, vol. 32, no. 4, p. 259-269.
Hamal, P. Současné možnosti typizace kandid. Sborník abstrakt Celostátní konference epidemiologie a
mikrobiologie. Plzeň, 1996, s. 10.
20. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Hamal, P., Raclavský, V. Molekulární metody typizace kandid. Sborník abstrakt 1. Česko-Slovenské
mezioborové konference lékařské mykologie. Pardubice, 1997, s. 13.
21. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Hamal, P., Raclavský, V., Zelenková, I. Typizace nozokomiálních kandid genetickými metodami přehled a vlastní zkušenosti. Sborník abstrakt III. společné konference SSI a ČSIL. Trenčianské Teplice,
1998, s. 28.
22. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Hamal, P., Raclavský, V., Zelenková, I. Molecular-genetic methods in the diagnostics of systemic
candidiasis. Abstract’s book of the 21st Congress of the Czechoslovak Society for Microbiology. Hradec
Králové, 1998, p. 32.
23. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Citace prací se spoluautorstvím:
Dostál, J., Hamal, P., Pavlíčková, L., Souček, M., Ruml, T., Pichová, I., Hrušková-Heidingsfeldová, O.
Simple method for screening Candida species isolates for the presence of secreted proteinases: a tool for
the prediction of successful inhibitory treatment. J. Clin. Microbiol., 2003, vol. 41, no. 2, p. 712-716.
24. Nicolatou-Galitis, O., Velegraki, A., Paikos, S., Economopoulou, P., Stefaniotis, T.,
Papanikolaou, I.S., Kordossis, T. Effect of PI-HAART on the prevalence of oral lesions in
HIV-1 infected patients. A Greek study. Oral Dis., 2004, vol. 10, no. 3, p. 145-150. (SCI)
25. dos Santos, A.L.S., Soares, R.M. Candida guilliermondii isolated from HIV-infected
human secretes a 50 kDa serine proteinase that cleaves a broad spectrum of proteinaceous
substrates. FEMS Immunol. Med. Microbiol., 2005, vol. 43, no. 1, p. 13-20. (SCI)
26. Asencio, M.A., Garduno, E., Perez-Giraldo, C., Blanco, M.T., Hurtado, C., GomezGarcia, A.C. Exposure to therapeutic concentrations of ritonavir, but not saquinavir,
reduces secreted aspartyl proteinase of Candida parapsilosis. Chemotherapy, 2005, vol.
51, no. 5, p. 252-255. (SCI)
27. Kalkanci, A., Bozdayi, G., Biri, A., Kustimur, S. Distribution of secreted aspartyl
proteinases using a polymerase chain reaction assay with SAP specific primers in Candida
albicans isolates. Folia Microbiol., 2005, vol. 50, no. 5, p. 409-413. (SCI)
28. dos Santos, A.L.S., de Carvalho, I.M., da Silva B.A., Portela M.B., Alviano C.S., Soares
R.M.D. Secretion of serine peptidase by a clinical strain of Candida albicans: influence of
growth conditions and cleavage of human serum proteins and extracellular matrix
components. FEMS Immunol. Med. Microbiol., 2006, vol. 46, no. 2, p. 209-220. (SCI)
29. Oksuz, S., Sahin, I., Yildirim, M., Gulcan, A., Yavuz, T., Kaya, D., Koc, A.N.
Phospholipase and proteinase activities in different Candida species isolated from
anatomically distinct sites of healthy adults. Jpn. J. Infect. Dis., 2007, vol. 60, no. 5, p.
280-283. (SCI)
30. Staib, P., Hermann, U., Blaß-Warmuth, J., Degel, B., Würzner, R., Monod, M.,
Schirmeister, T., Morschhäuser, J. Tetracycline-inducible expression of individual
secreted aspartic proteases in Candida albicans allows isoenzyme-specific inhibitor
screening. Antimicrob. Agents Chemother., 2008, vol. 52, no. 1, p. 146-156. (SCI)
31. Kosalec, I., Pepeljnjak, S., Matica, B., Jarza-Davila, N. Virulence factors of yeast
Candida albicans. Farm. Glas., 2005, vol. 61, no. 6, p. 381-396.
32. Álvares, C.A., Svidzinski, T.I.E., Consolaro, M.E.L. Vulvovaginal candidiasis:
susceptibility factors of the host and virulence of the yeast. J. Bras. Patol. Med. Lab.
2007, vol. 43, no. 5, p. 319-327.
33. Thiele, M.C., Carvalho, A.D., Gursky, L.C., Rosa, R.T., Samaranayake, L.P., Rosa, E.A.
The role of candidal histolytic enzymes on denture-induced stomatitis in patients living in
retirement homes. Gerodontology, 2008, doi:10.1111/j.1741-2358.2008.00221.x
34. Avşar, K. In vivo-Expressionsnachweis sekretorischer Aspartylproteinasen von Candida
albicans bei Patientinnen mit einer akuten Vaginalkandidose. Dissertation zum Erwerb
des Doktorgrades der Medizin. München: Medizinische Fakultät der LudwigMaximilians-Universität, 2005.
35. Lobaina Rodríguez, T., Rodríguez Martinez, C., Zhurbenko, R., García Marichal, J.M.,
Zayas Ruiz, Y. Nutrient medium for yeast culture. Patent no. WO 2007/071204 A1.
Solicitud internacional publicada en virtud del tratado de cooperación en materia de
patentes (http://v3.espacenet.com/origdoc?DB=EPODOC&IDX=WO2007071204&F=0&
QPN=WO2007071204)
Plachý, R., Hamal, P., Raclavský, V. McRAPD as a new approach to rapid and accurate identification of
pathogenic yeasts. J. Microbiol. Meth., 2005, vol. 60, no. 1, p. 107-113.
36. Bialková, A., Šubík, J. Biology of the pathogenic yeast Candida glabrata. Folia
Microbiol. 2006, vol. 51, no. 1, p. 3-20. (SCI)
37. Toubas, D., Essendoubi, M., Adt, I., Pinon, J.-M., Manfait, M., Sockalingum, G.D. FTIR
spectroscopy in medical mycology: applications to the differentiation and typing of
Candida. Anal. Bioanal. Chem., 2007, vol. 387, no. 5, p. 1729-1737 (SCI)
38. Balajee, S.A, Sigler, L., Brandt, M.E. DNA and the classical way: Identification of the
medically important molds in the 21st century. Med. Mycol., 2007, vol. 45, no. 6, p. 475490. (SCI)
39. De Baere, T., Van Keerberghen, A., Van Hauwe, P., De Beenhouwer, H., Boel, A.,
Verschraegen, G., Claeys, G., Vaneechoutte, M. An interlaboratory comparison of ITS2PCR for the identification of yeasts, using the ABI Prism 310 and CEQ8000 capillary
electrophoresis systems. BMC Microbiol., 2005, vol. 5, art. 14.
40. Liu, J., Xiang, M., Zhang, H. Application of randomly amplified polymorphic DNA
typing in detecting Candida mycoderma in nosocomial infections. J. Diagn. Concepts
Pract., 2007, vol. 6, no. 2, p. 169-171.
41. Viktorinová, M., Ditrichová, D. Kvasinková paronychia. Dermatologie, 2007, roč. 1, čís.
1, s. 16-18.
Raclavský V., Trtková, J., Rusková, L., Buchta, V., Bolehovská, R., Vacková, M., Hamal, P. Primer
R108 performs best in the RAPD strain typing of three Aspergillus species frequently isolated from
patients. Folia Microbiol., 2006, vol. 51, no. 2, p. 136-140.
42. Bain, J.M., Tavanti, A., Davidson, A.D., Jacobsen, M.D., Shaw, D., Gow, N.A.R., Odds,
F.C. Multilocus sequence typing of the pathogenic fungus Aspergillus fumigatus. J. Clin.
Microbiol., 2007, vol. 45, no. 5, p. 1469-1477. (SCI)
43. Settanni, L., Corsetti, A. The use of multiplex PCR to detect and differentiate food- and
beverage-associated microorganisms: a review. J. Microbiol. Methods, 2007, vol. 69, no.
1, p. 1-22. (SCI)
Hejnar P., Hamal P., Koukalová D. Influence of an extended incubation period on values of minimum
inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains. Microbiologica,
2000, vol. 23, no. 4, p. 415-421.
44. Cloud-Hansen, K.A., Villiard, K.M., Handelsman, J., Carey, H.V. Thirteen-lined ground
squirrels (Spermophilus tridecemlineatus) harbor multiantibiotic-resistant bacteria. J. Am.
Assoc. Lab. Anim. Sci. 2007, vol. 46, no. 3, p. 21-23. (SCI)
45. Nie, D.-P., Wang, Ch.-L., Du, W.-D., Kuan, S.-W. Activities of quinolones combined
with β-lactam/β-lactamase inhibitors against Stenotrophomonas maltophilia. Chinese
Journal of Antibiotics, 2002, vol. 27, no. 11, p. 673-676.
46. Belokrysenko, S.S., Dadkhah Tehrani, A. Stenotrophomonas maltophilia – an important
nosocomial pathogen and challenge for clinicians, microbiologists and hospital
epidemiologists. Overview. Laboratoř klinické mikrobiologie a kontroly nemocničních
infekcí Vědeckovýzkumného centra Moskevské lékařské akademie I.M.Sečenova, 2005,
http://www.mma.ru/rescenter/lab/micbio/obzor/from20
47. Dülger, D., Berktaş, M., Bozkurt, H., Güdücüoğlu, H., Mısırlıgil, A. The isolation and
antibiotic susceptibility of nosocomial Stenotrophomonas maltophilia strains. Van Tıp
Dergisi, 2006, vol. 13, no. 2, p. 49-52.
Bolehovská, R., Plíšková, L., Buchta, V., Cerman, J., Hamal, P. Detection of Aspergillus spp. In
biological samples by real-time PCR. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub.,
2006, vol. 150, no.2, p. 245-248.
48. Campa, D., Tavanti, A., Gemignani, F., Mogavero, C.S., Bellini, I., Bottari, F., Barale, R.,
Landi, S., Senesi, S. DNA microarray based on arrayed-primer extension technique for
identification of pathogenic fungi responsible for invasive and superficial mycoses. J.
Clin. Microbiol., 2008, vol. 46, no. 3, p. 909-915.
49. Bastola, D.R., Chandio, S.H., Iwen, P.C., Hinrichs, S.H., Ali, H. RFLP-WAWE analysis
for rapid identification of medically important fungi. Proceedings of the 41st Hawaii
International Conference on System Sciences. Hawaii, 2008, p. 229,
doi:10.1109/HICSS.2008.379.
Faber, E., Riegrová, D., Jarošová, M., Hubáček, J., Slezák, P. Pikalová, Z., Hamal, P., Indrák, K.
Abdominal zygomycotic thromboangiitis in a patient with AML and t(1;13;14). Ann. Hematol., 1996, vol.
73, p. 195-198.
50. Gleissner, B., Schilling, A., Anagnostopoulos, I., Siehl, I., Thiel, E. Improved outcome of
zygomycosis in patients with hematological diseases? Leuk. Lymphoma, 2004, vol. 45, no.
7, p. 1351-1360. (SCI)
Buchta, V., Kolář, M., Bergerová, T., Chmelařová, E., Mallátová, N., Horová, B., Hamal, P., Pozlerová,
E., Horníková, M., Dobiášová, S. Výskyt potenciálně patogenních kvasinek ve velkých nemocnicích v
České republice. Klin. Mikrobiol. Inf. Lék., 1998, roč. 4, čís. 1, s. 10-17.
51. Bialková, A., Šubík, J. Biology of the pathogenic yeast Candida glabrata. Folia
Microbiol., 2006, vol. 51, no. 1, p. 3-20.
52. Haber, J., Mallátová, N., Kocmanová, I. Invazivní mykózy. Epidemiologie, diagnostika a
léčba. Praha: Pfizer, spol.s.r.o., 2007.
53. Haber, J., Mallátová, N., Kolešková, E., Hnátková, M., Kořen, J. Epidemiologie invazivní
kandidózy a kandidémie – stále aktuální problém. Anest. Intenziv. Med., 2008, roč. 19, čís.
2, s. 114-123.
54. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Hejnar, P., Kolář, M., Hájek, V., Koukalová, D., Hamal, P. Occurence of variants with temperaturedependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains. Folia
Microbiol., 2001, vol. 46, no. 2, p. 151-155.
55. Dülger, D., Berktaş, M. The clinical importance of Stenotrophomonas maltophilia strains.
Van Tıp Dergisi, 2007, vol. 14, no. 3, p. 90-95.
Viktorinová, M., Hamal, P. Klinické zkušenosti s 1% oxikonazolnitrátem v místní léčbě houbových
kožních infekcí. Čs. Derm., 1994, roč. 69, čís. 3, s. 138-143.
56. Jautová, J., Jarčušková, D., Šimuničová, E., Schneiderová, T. Tolciclate v liečbe
kvasinkovej plienkovej dermatitídy u detí. Čes.-slov. Pediat., 1996, roč. 51, čís. 12, s.
729-732.
Vlčková, I., Klačanský, J., Hamal, P., Hartlová, M. Aspergilová sphenoiditida s následným
jednostranným oslepnutím. Choroby hlavy a krku, 1997, roč. 6, čís. 1, s. 19-21.
57. Andrašovská, M., Mudrák, J., Kovaľ, J. Mykotická sinusitída. Otorinolaryng. a Foniat.,
2003, roč. 52, čís. 1, s. 18-21.
The Czech Leukemia Study Group for Life: Bartáková, H., Cetkovský, P., Drgoňa L., Haber, J., Hamal,
P., Kocmanová, I., Kouba, M., Koukalová, D., Lengerová, M., Mallátová, N., Mayer, J., Mencl, K., Ráčil,
Z., Tesařová, M. Invazivní aspergilóza: současné možnosti diagnostiky. Ráčil, Z., Mayer, J. (eds.). Vnitř.
lék., 2007, roč. 53, suppl., s. S1-S34.
58. Faber, E. Invazivní aspergilóza: je čas na optimizmus? – editorial. Vnitř. lék., 2008, roč.
54, čís. 2, s. 133-134.
Koukalová, D., Hamal, P., Hájek, V., Koďousek, R.: Vakcína k léčbě vleklých kvasinkovitých zánětů
pochvy. Klin. Mikrobiol. Inf. Lék., 1998, roč. 4, čís. 2, s. 59-62.
59. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Kročová, Z., Koukalová, D., Hernychová, L., Macela, A., Kroča, M., Hájek, V., Hamal, P.
Imunomodulační vlastnosti vakcíny KANVAKOL. Klin. Mikrobiol. Inf. Lék., 1998, roč. 4, čís. 3, s. 90-94.
60. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.
Raclavský, V., Hamal, P., Zelenková, I. Diferenciace lékařsky významných kandid biotypizací, PFGE a
RAPD. Sborník abstrakt 1. Česko-Slovenské mezioborové konference lékařské mykologie. Pardubice,
1997, s. 73.
61. Šandula, J., Tomšíková, A. Immunology and pathogenicity. In: Biely, P. (ed.) Forty years
of activity in Czech and Slovak yeast research. Period 1990-1999. Bratislava: Veda, 1999,
p. 93-106.